PULM

$0.00

(

+0.00%

)
Quote details

stock

Pulmatrix Inc

NASDAQ | PULM

4.58

USD

(

+0.00%

)

At Close (As of Jan 1, 1970)

$14.46M

Market Cap

-

P/E Ratio

-1.71

EPS

$10.40

52 Week High

$3.90

52 Week Low

HEALTHCARE

Sector

PULM Chart

Recent Chart
Price Action

PULM Technicals

Tags:

PULM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $640K
Total Revenue $7.8M
Cost Of Revenue $7.2M
Costof Goods And Services Sold $7.2M
Operating Income -$9.8M
Selling General And Administrative $7.8M
Research And Development $7.2M
Operating Expenses $10M
Investment Income Net -
Net Interest Income $467K
Interest Income $467K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $106K
Income Before Tax -$9.6M
Income Tax Expense -$9.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$9.6M
Comprehensive Income Net Of Tax -
Ebit -$7.1M
Ebitda -$7M
Net Income -$9.6M

Revenue & Profitability

PULM Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $640K
Total Revenue $7.8M
Cost Of Revenue $7.2M
Costof Goods And Services Sold $7.2M
Operating Income -$9.8M
Selling General And Administrative $7.8M
Research And Development $7.2M
Operating Expenses $10M
Investment Income Net -
Net Interest Income $467K
Interest Income $467K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $106K
Income Before Tax -$9.6M
Income Tax Expense -$9.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$9.6M
Comprehensive Income Net Of Tax -
Ebit -$7.1M
Ebitda -$7M
Net Income -$9.6M

PULM News

PULM Profile

Pulmatrix Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Pulmatrix, Inc. is a clinical-stage biopharmaceutical firm based in Lexington, Massachusetts, specializing in the development of inhaled therapies aimed at treating respiratory diseases and serious conditions with significant unmet medical needs. Leveraging its proprietary inhalation drug delivery technologies, the company is advancing a robust pipeline of innovative treatments designed to improve patient outcomes and enhance quality of life. With a strategic commitment to key therapeutic areas, Pulmatrix is well-positioned to be a crucial contributor in the dynamic field of respiratory medicine.

LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
OCG
-75.85%
$0.22
YCBD
+90.17%
$1.20
NVDA
-3.26%
$175.02
CGC
+53.98%
$1.74
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.70%
$458.96
AVGO
-11.42%
$359.93
ONDS
-2.99%
$8.75
INTC
-4.30%
$37.81
TLRY
+44.12%
$12.15
ATPC
-25.11%
$0.13
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-29.95%
$0.14
TE
-8.85%
$5.35
ASBP
-9.09%
$0.09
ORCL
-4.46%
$189.97
SOFI
+0.77%
$27.28
VIVK
-1.75%
$0.07
BMNR
-9.17%
$34.86
PFE
+0.19%
$25.85
ZDGE
+14.40%
$2.78
ADAP
-15.14%
$0.05
DNN
-5.43%
$2.61
HPE
-2.73%
$23.87
NFLX
+1.16%
$95.19
F
+0.95%
$13.76
AAL
0.00%
$14.96
PLTD
+2.21%
$6.46
KVUE
+0.05%
$17.33
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
WULF
-9.47%
$14.33
UGRO
+38.07%
$0.33
MARA
-2.70%
$11.52
SOND
-23.45%
$0.12
PLTR
-2.11%
$183.57
RR
-11.96%
$4.12
BMNU
-18.78%
$8.30
BYND
-7.62%
$1.09
VALE
-2.76%
$12.69
BAC
+1.06%
$55.14
RMBL
+60.50%
$3.21
AAPL
+0.08%
$278.28
LNW
-3.71%
$86.22
ACHR
-3.03%
$8.30
APLT
-45.91%
$0.11
SNAP
-4.31%
$7.31
ADD
-25.47%
$0.05
CLSK
-5.33%
$14.03
BITF
-6.80%
$2.74
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
AMZN
-1.77%
$226.19
IREN
-8.67%
$40.13
IRBT
-13.60%
$4.32
CRWV
-10.05%
$78.59
BTG
-1.70%
$4.60
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
T
+1.15%
$24.58
RIG
-3.50%
$4.13
RKLB
-3.21%
$61.49
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
CVE
+1.74%
$18.03
HOOD
-3.14%
$119.50
CIFR
-9.69%
$17.05
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB
-0.57%
$5.15
CAN
-9.05%
$0.84
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MTSR
-0.35%
$70.50
SOUN
-3.15%
$11.65
CHR
0.00%
$0.04
ABEV
+2.00%
$2.55
MU
-6.70%
$241.14
HL
-2.79%
$18.81
JBLU
+1.02%
$4.94
KIND
-14.44%
$2.37
NXDR
-14.44%
$2.37
IBRX
+7.76%
$2.36
AG
-5.17%
$15.94
NOK
-1.41%
$6.27
APLD
-9.42%
$27.86
BTBT
-8.53%
$2.25
CDE
-1.31%
$17.25
LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
OCG
-75.85%
$0.22
YCBD
+90.17%
$1.20
NVDA
-3.26%
$175.02
CGC
+53.98%
$1.74
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.70%
$458.96
AVGO
-11.42%
$359.93
ONDS
-2.99%
$8.75
INTC
-4.30%
$37.81
TLRY
+44.12%
$12.15
ATPC
-25.11%
$0.13
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-29.95%
$0.14
TE
-8.85%
$5.35
ASBP
-9.09%
$0.09
ORCL
-4.46%
$189.97
SOFI
+0.77%
$27.28
VIVK
-1.75%
$0.07
BMNR
-9.17%
$34.86
PFE
+0.19%
$25.85
ZDGE
+14.40%
$2.78
ADAP
-15.14%
$0.05
DNN
-5.43%
$2.61
HPE
-2.73%
$23.87
NFLX
+1.16%
$95.19
F
+0.95%
$13.76
AAL
0.00%
$14.96
PLTD
+2.21%
$6.46
KVUE
+0.05%
$17.33
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
WULF
-9.47%
$14.33
UGRO
+38.07%
$0.33
MARA
-2.70%
$11.52
SOND
-23.45%
$0.12
PLTR
-2.11%
$183.57
RR
-11.96%
$4.12
BMNU
-18.78%
$8.30
BYND
-7.62%
$1.09
VALE
-2.76%
$12.69
BAC
+1.06%
$55.14
RMBL
+60.50%
$3.21
AAPL
+0.08%
$278.28
LNW
-3.71%
$86.22
ACHR
-3.03%
$8.30
APLT
-45.91%
$0.11
SNAP
-4.31%
$7.31
ADD
-25.47%
$0.05
CLSK
-5.33%
$14.03
BITF
-6.80%
$2.74
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
AMZN
-1.77%
$226.19
IREN
-8.67%
$40.13
IRBT
-13.60%
$4.32
CRWV
-10.05%
$78.59
BTG
-1.70%
$4.60
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
T
+1.15%
$24.58
RIG
-3.50%
$4.13
RKLB
-3.21%
$61.49
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
CVE
+1.74%
$18.03
HOOD
-3.14%
$119.50
CIFR
-9.69%
$17.05
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB
-0.57%
$5.15
CAN
-9.05%
$0.84
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MTSR
-0.35%
$70.50
SOUN
-3.15%
$11.65
CHR
0.00%
$0.04
ABEV
+2.00%
$2.55
MU
-6.70%
$241.14
HL
-2.79%
$18.81
JBLU
+1.02%
$4.94
KIND
-14.44%
$2.37
NXDR
-14.44%
$2.37
IBRX
+7.76%
$2.36
AG
-5.17%
$15.94
NOK
-1.41%
$6.27
APLD
-9.42%
$27.86
BTBT
-8.53%
$2.25
CDE
-1.31%
$17.25

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.